ADAP
Adaptimmune Therapeutics
ADAP
ADAP
68 hedge funds and large institutions have $122M invested in Adaptimmune Therapeutics in 2022 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 20 increasing their positions, 15 reducing their positions, and 18 closing their positions.
Holders
68
Holders Change
-9
Holders Change %
-11.69%
% of All Funds
1.18%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
10
Increased
20
Reduced
15
Closed
18
Calls
$78K
Puts
$2K
Net Calls
+$76K
Net Calls Change
-$73K